A Comparison of the Effects of Quinolinate and N-methyl-aspartate on Neurons in Rat Piriform Cortex
Overview
Authors
Affiliations
Quinolinate has been proposed to be the endogenous ligand of the N-methyl-aspartate (NMA) receptor in the mammalian central nervous system. We have compared the relative potency and pharmacologic sensitivity of quinolinate- and NMA-induced excitation on pyramidal cells in the rat piriform cortex. Quinolinate was considerably less potent than NMA, but the NMA responses were more sensitive to antagonism by NMA-receptor antagonists. These results suggest that, at least in this preparation, quinolinate and NMA are pharmacologically distinguishable and may act at different receptor sites.
Pawley A, Flesher S, Boegman R, Beninger R, Jhamandas K Br J Pharmacol. 1996; 117(6):1059-64.
PMID: 8882597 PMC: 1909798. DOI: 10.1111/j.1476-5381.1996.tb16697.x.
Magnuson D, Curry K, Peet M, McLennan H Exp Brain Res. 1988; 73(3):541-5.
PMID: 2906296 DOI: 10.1007/BF00406612.
Burton N, Smith D, Stone T Br J Pharmacol. 1988; 93(3):693-701.
PMID: 2897220 PMC: 1853850. DOI: 10.1111/j.1476-5381.1988.tb10328.x.
Wood P, Rao T, Iyengar S, Lanthorn T, Monahan J, Cordi A Neurochem Res. 1990; 15(2):217-30.
PMID: 2159127 DOI: 10.1007/BF00972212.
Winn P, Stone T, Latimer M, Hastings M, Clark A Br J Pharmacol. 1991; 102(4):904-8.
PMID: 1677299 PMC: 1917971. DOI: 10.1111/j.1476-5381.1991.tb12274.x.